The Omicron variant of the coronavirus does not have a negative effect on cardiovascular health in young adults who have been vaccinated, a small study suggests. Additionally, women should not delay routine mammograms after receiving a COVID-19 mRNA vaccine, experts now say.
Texas doctor calls U.S. COVID deaths nearing 1 million ‘mindblowing’
“Long-Haul” COVID-19, Asymptomatic Patients, BNT162b2 (Pfizer and BioNTech), Breakthrough COVID-19, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Disease 2019 (COVID-19), Coronavirus Restrictions, Coronavirus surge, Coronavirus Vaccines, COVID guidelines, COVID-19 anti-vaxxers, Covid-19 asymptomatic infections, COVID-19 cases, COVID-19 Deaths, Covid-19 fatality rate, COVID-19 inoculations, COVID-19 misinformation, COVID-19 Prevention Measures, COVID-19 protocols, COVID-19 recommendations, COVID-19 risk, COVID-19 Severe Complications, COVID-19 Vaccines, Deaths, Janssen COVID-19 Vaccine (J&J), Mask-wearing, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Pandemics, Therapeutics, Vaccines, Vaxzevria (previously COVID-19 Vaccine AstraZeneca)In the early days of the COVID-19 pandemic, pulmonologist Joseph Varon offered an opinion that made headlines around the world and went viral on social media. Varon was fighting two wars, he said: one against COVID and one against stupidity.
Fourth shot protects against severe Omicron outcomes; COVID may increase risk of rare eye blood clots
Blood Clots, Blood Vessels, BNT162b2 (Pfizer and BioNTech), Breakthrough COVID-19, COVID-19 booster shots, COVID-19 Infections, COVID-19 shots, COVID-19 Studies, COVID-19 Vaccines, Eye Conditions, Hospitalized COVID-19 Patients, Israel, New England Journal of Medicine, Omicron (B.1.1.529) (South Africa), SARS-CoV-2 virusA fourth dose of the COVID-19 vaccine from Pfizer and BioNTech provided significant added protection against severe disease, hospitalization and death for at least a month in older individuals, according to a study from Israel conducted when the Omicron variant was dominant. Additionally, new findings suggest patients with COVID-19 may have an increased risk of rare vision-threatening blood clots in the eye for months afterward.
EXCLUSIVE: U.S. seeks to expand Trump-era COVID data collection under CDC
Breakthrough COVID-19, CDC, Coronavirus Disease (COVID-19) Pandemic, COVID-19 booster shots, COVID-19 shots, Data Tracking, Department of Health and Human Services (HHS), Donald Trump, Hospitalized patients, Hospitals, Infectious Diseases, Joe Biden, National Healthcare Safety Network (NHSN), Patients, Respiratory DiseaseThe Biden administration wants to expand a federal COVID-19 tracking system created during the pandemic to provide a more detailed view of how respiratory and other infectious diseases are affecting patients and hospital resources, according to a draft of proposed rules reviewed by Reuters.
1 in 5 Americans Have had COVID-19, Veklury Approved in New Indication
BNT162b2 (Pfizer and BioNTech), Breakthrough COVID-19, CDC, Centers for Medicare and Medicaid Services (CMS), Coronavirus Disease (COVID-19) Pandemic, COVID-19 Infections, COVID-19 Vaccines, Dr. Anthony Fauci (Director), Expanded Approval, FBI, FDA/Regulatory, Kids, National Institute of Allergy and Infectious Diseases (NIAID), Omicron (B.1.1.529) (South Africa), Remdesivir, United StatesAt least 1 in 5 Americans have been infected with COVID-19. In other news, the U.S. Food and Drug Administration approved Gilead Sciences’ supplemental New Drug Application for Veklury (remdesivir) for adults and adolescents with COVID-19 who are not hospitalized but are at high risk of progression to severe COVID-19, hospitalization or death.
Small children getting less sick from Omicron; Genetic mutation protects against severe COVID
BNT162b2 (Pfizer and BioNTech), Breakthrough COVID-19, Children, COVID-19 Vaccines, Delta Variant (B.1.617.2; India), Genetic Mutations, JAMA, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Nature Genetics, Omicron (B.1.1.529) (South Africa), R&D, Researchers, Severe Covid-19In very young children, the Omicron variant of the coronavirus causes less severe disease than the Delta variant, according to a new study. In other research, new findings add to evidence that people with a certain version of a gene are less likely to develop severe COVID-19.
Johnson & Johnson said on January 6 that a real-world study showed the company’s single shot Covid-19 vaccine protects against breakthrough infections and hospitalizations for up to six months.
A new study shows the persistent syndrome of Covid-19 after-effects known as long Covid can develop after “breakthrough” infections in vaccinated people. Other new findings suggest a gene that helps the coronavirus reproduce itself might contribute to life-threatening Covid-19 in young, otherwise healthy people.
Evidence is emerging that not only can Covid-19 vaccines help prevent long Covid, but they could serve as a form of “rescue” for those already stricken with the condition.
Illinois will require all eligible students and school employees to be vaccinated and re-instituted an indoor mask mandate under an order announced by Governor J.B. Pritzker on Aug. 26.